Hepatology News

A test-and-treat model for hepatitis C virus infection among injection drug users and people experiencing homelessness resulted in high levels of treatment initiation, completion and cure, and may expand care access to marginalized groups.

BOSTON — In this video, Tatyana Kushner, MD, MSCE, spoke with Healio about interim results from a study investigating treatment of hepatitis c virus infection in pregnant people.

BOSTON — Tatyana Kushner, MD, MSCE, spoke with Healio about rapid testing options for hepatitis C virus to improve the cascade of care.

BOSTON — Although primary care physicians play a vital role in managing metabolic dysfunction-associated steatotic liver disease, many are not following guidance on screening, risk stratification or referrals, according to research.

BOSTON — Patients with metabolic dysfunction-associated steatotic liver disease who underwent bariatric surgery lost less weight over 5 years than those without MASLD, according to research presented at The Liver Meeting.

During an introductory press briefing, new NIH Director Monica M. Bertagnolli, MD, FACS, FASCO, called for a greater focus in clinical research to improve access to care.

BOSTON — In this video, Tatyana Kushner, MD, MSCE, discusses the “significant focus” at The Liver Meeting on the elimination of hepatitis C virus.

Historically in the United States, Medicare has not had the legal authority to negotiate the prices of drugs. Essentially, drug prices were unregulated.

Tenofovir disoproxil improved long-term overall and recurrence-free survival rates compared with entecavir among patients with hepatitis B virus-related hepatocellular carcinoma who underwent liver resection.

BOSTON — Women who experience food insecurity and have a BMI less than 25 kg/m2 had higher odds of hepatic steatosis compared with overweight women or those with obesity, regardless of HIV status, according to research at The Liver Meeting.